Mesoblast (MEOBF) Non Operating Interest Expenses (2014 - 2023)

Mesoblast has disclosed Non Operating Interest Expenses across 10 years of filings, most recently posting -$3.8 million for Q2 2023.

• In Q2 2023, Non Operating Interest Expenses rose 4.58% year-over-year to -$3.8 million; the TTM figure through Jun 2023 stood at -$19.4 million (down 15.01% YoY), while the FY2026 annual figure was -$19.9 million, up 8.65% from the prior year.
• Non Operating Interest Expenses came in at -$3.8 million for Q2 2023 at Mesoblast, up from -$5.0 million in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of -$1.1 million in Q4 2020 to a low of -$9.8 million in Q1 2020.
• Average Non Operating Interest Expenses over 5 years is -$4.6 million, with a median of -$3.9 million recorded in 2022.
• Year-over-year, Non Operating Interest Expenses plunged 554.37% in 2019 and soared 83.41% in 2020.
• Over 5 years, Non Operating Interest Expenses stood at -$6.4 million in 2019, then soared by 83.41% to -$1.1 million in 2020, then slumped by 406.59% to -$5.4 million in 2021, then decreased by 15.02% to -$6.2 million in 2022, then jumped by 39.01% to -$3.8 million in 2023.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were -$3.8 million in Q2 2023, -$5.0 million in Q1 2023, and -$6.2 million in Q4 2022.